Upregulation of TIMP-1 expression has also been identified as a potential resistance mechanism of pancreatic tumors against gemcitabine, and has been implicated in clonogenic survival of pancreatic cancer cells as well as vascular density [118]. Here, TIMP1 is linked to familial pancreatic carcinoma.